CRISPR-Cas9 Gene Editing Technologies Market: Information By Application (Genome Engineering, Disease Models, RNA Editing & Knockdown), By End Users and Regional Outlook — Forecast Till 2026

Jun 12, 2019   Global Statistics Representing CRISPR-Cas9 Gene Editing Technologies Market Scenario Gene editing is the modern biotechnological technique designed to alter the genomes of living organisms for health or economic benefits. Nowadays, gene editing is not only used in the medical sector but also in the agricultural sector. CRISPR-Cas9 is a newly introduced and improved technology which effectively and specifically alter genes within organisms. CRISPR-Cas9 has found wide array of applications in bio...
Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: CRISPR-Cas9 Gene Editing Technologies Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Application Overview

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

4.2       Genome Engineering

4.2.1    Market Size & Forecast (Value)

4.3       Disease Models

4.3.1    Market Size & Forecast (Value)

5          By End-User Overview

5.1       Introduction

5.1.1    Market Size & Forecast (Value)

5.2       Biotechnology & Pharmaceutical Companies

5.2.1    Market Size & Forecast (Value)

5.3       Academic & Government Research Institutes

5.3.1    Market Size & Forecast (Value)

6          Regional Overview

6.1       Introduction

6.1.1    Market Size & Forecast (Value)

6.2       America

6.2.1    North America

6.2.1.1 U.S.

6.2.1.1.1          By Application

6.2.1.1.2          By End-User

6.2.1.2 Canada

6.2.1.2.1          By Application

6.2.1.2.2          By End-User

6.2.1.3 Mexico

6.2.1.3.1          By Application

6.2.1.3.2          By End-User

6.2.1.4 Latin America

6.2.1.4.1          By Application

6.2.1.4.2          By End-User

6.3       Europe

6.3.1    Market Size & Forecast (Value)

6.3.2    Germany

6.3.2.1 By Application

6.3.2.2 By End-User

6.3.3    France

6.3.3.1 By Application

6.3.3.2 By End-User

6.3.4    U.K.

6.3.4.1 By Application

6.3.4.2 By End-User

6.3.5    Italy

6.3.5.1 By Application

6.3.5.2 By End-User

6.3.6    Spain

6.3.6.1 By Application

6.3.6.2 By End-User

6.3.7    Rest of Europe

6.3.7.1 By Application

6.3.7.2 By End-User

6.4       Asia Pacific

6.4.1    Market Size & Forecast (Value)

6.4.2    Japan

6.4.2.1 By Application

6.4.2.2 By End-User

6.4.3    China

6.4.3.1 By Application

6.4.3.2 By End-User

6.4.4    Australia

6.4.4.1 By Application

6.4.4.2 By End-User

6.4.5    India

6.4.5.1 By Application

6.4.5.2 By End-User

6.4.6    South Korea

6.4.6.1 By Application

6.4.6.2 By End-User

6.4.7    Rest of Asia-Pacific

6.4.7.1 By Application

6.4.7.2 By End-User

6.5       Middle East & Africa

6.5.1    Market Size & Forecast (Value)

6.5.2    Saudi Arabia

6.5.2.1 By Application

6.5.2.2 By End-User

6.5.3    South Africa

6.5.3.1 By Application

6.5.3.2 By End-User

6.5.4    Kuwait

6.5.4.1 By Application

6.5.4.2 By End-User

6.5.5    Rest of Middle East & Africa

6.5.5.1 By Application

6.5.5.2 By End-User

7          Company Profile

7.1       Thermo Fisher Scientific (U.S.)

7.1.1    Company Overview

7.1.2    Financial Performance

7.1.3    Recent Developments

7.1.4    Product Portfolio

7.2       Merck & Co., Inc. (U.S.)

7.2.1    Company Overview

7.2.2    Financial Performance

7.2.3    Recent Developments

7.2.4    Product Portfolio

7.3       Genscript (U.S.)

7.3.1    Company Overview

7.3.2    Financial Performance

7.3.3    Recent Developments

7.3.4    Product Portfolio

7.4       Sangamo Therapeutics, Inc. (U.S.)

7.4.1    Company Overview

7.4.2    Financial Performance

7.4.3    Recent Developments

7.4.4    Product Portfolio

7.5       Integrated DNA Technologies, Inc. (U.S.)

7.5.1    Company Overview

7.5.2    Financial Performance

7.5.3    Recent Developments

7.5.4    Product Portfolio

7.6       Lonza (Switzerland)

7.6.1    Company Overview

7.6.2    Financial Performance

7.6.3    Recent Developments

7.6.4    Product Portfolio

7.7       New England Biolabs (U.S.)

7.7.1    Company Overview

7.7.2    Financial Performance

7.7.3    Recent Developments

7.7.4    Product Portfolio

7.8       CRISPR THERAPEUTICS (Switzerland)

7.8.1    Company Overview

7.8.2    Financial Performance

7.8.3    Recent Developments

7.8.4    Product Portfolio

            7.9       Mirus Bio LLC (U.S.)

7.9.1    Company Overview

7.9.2    Financial Performance

7.9.3    Recent Developments

7.9.4    Product Portfolio